Tirzepatide → Earache — Null result

← All findings ⬇ Download signed audit packet

Ledger entry · null-result

Tirzepatide → Earache — Null result

Drug: tirzepatide · AE: Earache

Caliper validation of the submitted claim (drug=tirzepatide, AE=Earache). BELOW_DEDUP_THRESHOLD — candidate did not validate at dedup

Disproportionality

PRR: 256.0670871633142 (95% CI 10.43–6286.02)
Yates χ²: 191.55802730864363
Cases (case-drug + AE): n = 0
Verdict: BELOW_DEDUP_THRESHOLD — candidate did not validate at dedup

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: ec501530b0b6273710fff80162aa7a30f062d7cf